JPS60186297A - Removal of nad+ activation inhibitor - Google Patents
Removal of nad+ activation inhibitorInfo
- Publication number
- JPS60186297A JPS60186297A JP4143684A JP4143684A JPS60186297A JP S60186297 A JPS60186297 A JP S60186297A JP 4143684 A JP4143684 A JP 4143684A JP 4143684 A JP4143684 A JP 4143684A JP S60186297 A JPS60186297 A JP S60186297A
- Authority
- JP
- Japan
- Prior art keywords
- nad
- activity
- enzyme
- inhibitors
- remove
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は高活性のニコチンアミドアデニンジヌクレオタ
イド(NAI)十という)の製造法に関するものである
。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing highly active nicotinamide adenine dinucleotide (NAI).
更に詳細には、NAI)+中に混在するNAD+活性阻
害物質を除去することによって高活性のNAD+金製造
する方法に関するものである。More specifically, the present invention relates to a method for producing highly active NAD+ gold by removing NAD+ activity inhibitors mixed in NAI)+.
一般に、NAD+は生化学研究や臨床検査の分野で今日
最も広く使用されている助酵素で25って、純度が高く
、高活性のものが望まれるものである。In general, NAD+ is the coenzyme most widely used today in the fields of biochemical research and clinical testing25, and it is desired to have high purity and high activity.
しかしながら、NAD+標品においても(7ばしば活性
の低下がみられるのである。However, even in NAD+ preparations (7), a decrease in activity is often observed.
活性の低下したNAD+標品について詳細に検討すると
、NAD十活性を阻害する物質が認められるのである。A detailed study of NAD+ preparations with reduced activity reveals substances that inhibit NAD+ activity.
NAD+活性阻害物質について検討しようとしても、分
離精製がきわめて困難なため現在阻害物質の構造並びに
性質については全く不明な状態である。Even if we try to study NAD+ activity inhibitors, the structure and properties of the inhibitors are currently completely unknown because separation and purification is extremely difficult.
しかし、NAD+標品にNAD+活性阻害物質が含まれ
ると、NAD+標品を使用する酵素活性測定の精度や酵
素反応解析に大きな影響を与えるために、NAD+活性
阻害物質は必ず除去しなければならないのである。NA
D十活性阻害物質の物性そのものが不明であるために、
該物質の分離法の手がかりすらつかめていないの力を現
状である。However, if NAD+ activity inhibitors are contained in NAD+ preparations, they must be removed, as this will have a significant impact on the accuracy of enzyme activity measurements and enzyme reaction analysis using NAD+ preparations. be. NA
Since the physical properties of the D10 activity inhibitor are unknown,
At present, we do not even have a clue as to how to separate this substance.
本発明者らは、NAI)十標品からNAD÷活性阻害物
質を除去するために鋭意研究したところ、NAD ”活
性阻害物質はNAD十依存性酵素に吸着され、NAD+
から分離されること全知ったのである。The present inventors conducted extensive research to remove NAD ÷ activity inhibitor from NAI) specimens, and found that NAD'' activity inhibitor was adsorbed to NAD-dependent enzyme, and NAD +
I knew everything about being separated from the world.
本発明は、NAD+活性阻害物質を含有するNAD +
とNAD4°依存性酵素の一棟もしくは二種以上とを緩
衝液中で一触は1て、NAI)+に含有されるN人り+
活性阻害物質を除去することを特徴とするNAD +活
性阻害物質除去不法である。The present invention provides NAD + containing an NAD + activity inhibitor.
and one or more types of NAD4°-dependent enzymes in a buffer solution, the amount of N contained in NAI)+ is reduced.
It is illegal to remove NAD + activity inhibitors, which is characterized by removing activity inhibitors.
本発明において、NAD+依存性酵素としては乳酸脱水
素酵素(LDH)、アルコール脱水酵素(A I) H
)、リンゴ酸脱水素酵(MDH)、ソルビトール脱水素
酵素(S D [()、グルタミン酸脱水素酵素(ol
Dtl)などがあげられるが、L D Hが最も好まし
い。In the present invention, NAD+ dependent enzymes include lactate dehydrogenase (LDH) and alcohol dehydrogenase (A I) H
), malate dehydrogenase (MDH), sorbitol dehydrogenase (S D [(), glutamate dehydrogenase (ol
Dtl), etc., but LDH is most preferred.
本発明にひいては、NAD 活性阻害物質を含有するN
AJ)+標品を適当な緩衝液中でLDHなどと共存させ
ると、阻害物質は急速にLDHなどに吸着され、NAJ
)4−’に回収することによって容易に阻6害物質ケ全
く含有しないNAD+を調製することができる。ここで
用いる緩衝液の種類としては、通常酵素反応に使用され
る緩衝液であればいずれでもよい。具体的には、リン酸
、トリス−塩酸、トリエタノールアミン−塩酸、ヒスチ
ジン−塩酸、グリシルグリシン、グツド緩衝液などがあ
る。緩衝液の濃度は10mMから500 mMいずれで
もよく、好ましくは50 mMから208 mMである
。According to the present invention, N containing an NAD activity inhibitor
When the AJ) + preparation is allowed to coexist with LDH etc. in an appropriate buffer solution, the inhibitory substance is rapidly adsorbed to LDH etc. and the NAJ
) 4-', NAD+ containing no inhibitory substances can be easily prepared. The type of buffer used here may be any buffer as long as it is normally used in enzyme reactions. Specific examples include phosphoric acid, Tris-hydrochloric acid, triethanolamine-hydrochloric acid, histidine-hydrochloric acid, glycylglycine, and Gud buffer. The concentration of the buffer solution may be anywhere from 10mM to 500mM, preferably from 50mM to 208mM.
また緩衝液の聞け5.5から90でよ5く、好ましくけ
ろ、0からZ5である。The strength of the buffer solution is preferably 5.5 to 90, preferably 0 to Z5.
また、NAD+依存性酵素としてはいずれの種類でも、
いずれの給源のものでもよい。L D Hの給源として
けうざぎ筋肉、ブタ心臓、ブタ筋肉、牛心臓、牛筋肉な
どの動物給源やロイコノストック、メヒンテロイデス、
高r品菌などの細菌給(IIちるいは植物給源などがあ
るが、いずれの給源からのI、D)(も使用できる。ま
゛た使用する酵素は溶液状態あるいは固定化状態いずれ
の形態でもよいが、NAD+標品の回収には固定化状態
のほうがより好、ましい。In addition, any type of NAD+ dependent enzyme,
It can be from any source. As sources of LDH, animal sources such as rabbit muscle, pig heart, pig muscle, bovine heart, bovine muscle, leuconostoc, mehinteroides,
Bacterial sources such as high-quality bacteria (II, plant sources, etc., but I, D) from any source can be used.Also, the enzyme used can be in either solution or immobilized form. However, the immobilized state is more preferable for recovering the NAD+ specimen.
酵素の固定化去りこは共佇結合法、イオン結庁法、物理
的吸M法、架橋法、包括法などがあり、一方、固定化担
体としては、ヒルロース、アガロース、デキストランな
どの多糖類、多孔性がシス、ポリアクリルアミド、カラ
ギーナン、ポリウレタンなどがあるがいずれの方法、し
よび1°は体でもよい。Enzyme immobilization methods include the co-binding method, ion binding method, physical absorption method, cross-linking method, and entrapment method.On the other hand, immobilization carriers include polysaccharides such as hillulose, agarose, and dextran. The porosity may be cis, polyacrylamide, carrageenan, polyurethane, etc., but any method may be used, and 1° may be used.
NAIL’とNAI)+依存性酵素は緩衝液中で接触ざ
すられるが、その接触反応昌度は2パCから40℃いず
れでもよく、好ましくは2℃から10℃でちる。NAIL' and NAI)+-dependent enzymes are brought into contact in a buffer solution, and the contact reaction temperature may be anywhere from 2°C to 40°C, preferably at 2°C to 10°C.
この処理によってNAD ’−活性阻害物質は酵素に吸
着式れるので、酵素を分離すれば高活性のNAI)+?
r−得ることができる。Through this treatment, NAD'-activity inhibitors are adsorbed onto the enzyme, so if the enzyme is separated, highly active NAI)+?
r- can be obtained.
酵素が固定化されている場合は、これ全カラムeこりめ
、NAD+標品をぽ汀する緩衝液を流ド(7、強中でN
AI)+活性阻害物質を酵素に吸着させて商店+’tの
NAI)”i直)妾f種ることかできる。If the enzyme is immobilized, drain the entire column with a buffer solution that retains the NAD+ sample (7.
AI) + activity inhibitors can be adsorbed onto enzymes to create a variety of products.
次に本発明の実施例を示す。Next, examples of the present invention will be shown.
太施I111゜
10 (] +nM IJ 7酸緩衝液(p)16.5
)にNAD+粉末約1[JO//l17’i溶解し4N
KOHでpH@ 6.0にA整した後、そこへ約10,
000単位のI、 D Hを入れ、10℃で10分間反
応ざ+!:た。Taishi I111゜10 (] +nM IJ 7 acid buffer (p) 16.5
) to dissolve about 1 NAD+ powder [JO//l17'i and 4N
After adjusting the pH to 6.0 with KOH, add it for about 10 minutes.
Add 000 units of I and D H and react at 10°C for 10 minutes! :Ta.
反応液全限外F迦し、F液を集め、LDHの除去され7
’cNAD”を回収する。回収したNAI)+溶液につ
いての分析結果を表1に示した。The entire reaction solution was subjected to ultraviolet F, the F solution was collected, and LDH was removed.
'cNAD' was collected. The analysis results for the collected NAI)+ solution are shown in Table 1.
尚、NAD+中の阻害物質の含付桿度はつぎの様にして
測定される。Incidentally, the degree of inclusion of the inhibitory substance in NAD+ is measured as follows.
0、1 MTris−[(Cl(pH8,5) 0.9
0m1.、80mMNAD 4−溶液(、pH8,5)
約8 u /mlウサギ筋肉LDH金キューベントに入
れ、25℃5分間インキュベーションを行う。その後4
0 mM L−乳酸全12d加え、分光光度計を用い2
5℃での1分間当りの吸光度変化fc測測定る。0,1 MTris-[(Cl(pH8,5) 0.9
0m1. , 80mM NAD 4-solution (pH 8,5)
Approximately 8 u/ml rabbit muscle LDH was placed in a gold cube and incubated at 25° C. for 5 minutes. then 4
Add 12 d of 0 mM L-lactic acid and add 2 d using a spectrophotometer.
Absorbance change per minute at 5°C is measured by fc measurement.
阻害物質を含有していないと思われる標準NAn+での
ΔAO7/ m i nとNAD+サンプルでのΔA
/ mi nとの比をめ、阻害物質の含有程度を相対活
性と表 1 液状LDHで処理した場合の
NAD十の品質
* 1.11M物質全含付したNAD+の処理に使用し
たLDHの絵心金示す。ΔAO7/min for the standard NAn+ that does not seem to contain inhibitors and ΔA for the NAD+ sample
Table 1 Quality of NAD+ when treated with liquid LDH * Eshinkin of LDH used for treatment of NAD+ containing all 1.11M substances show.
*hイ11+す2
ブロム/アン法で七フrロース30MにLDH3001
n9固定したL D Hゲル3mJiつめたカラムに0
.1 M K −PO,(p)J l O)金流しカラ
ムをモ衡化ざぎる。ついで100 m9.l ml N
A1.)+溶液(pH”10)1mlカラムへ流(2、
その後同じ緩衝液でNAD+を溶出した。*H11 + S2 LDH3001 to 7 frose 30M using Brom/Anne method
0 to a column packed with 3 mJi of n9-fixed LDH gel.
.. 1M K-PO, (p)JlO) Moisturize the gold flow column. Then 100 m9. l ml N
A1. ) + solution (pH”10) flow into 1 ml column (2,
NAD+ was then eluted with the same buffer.
カラノ・から回収されたNAI)+について、実施例1
と同様に分析を行った。分析結果を表1に示した。Example 1 Regarding NAI)+ recovered from Carano.
Analyzes were conducted in the same manner. The analysis results are shown in Table 1.
を 2 置屋化1. l) Hで処理した場合のNAI
)+の品質
固定化T、 D Hの給源を示す2 Establishment of an okiya 1. l) NAI when treated with H
) + quality fixed T, DH indicates the source of H
Claims (2)
AD ’−依存性酵素の一種もしくは二種以上とを緩衝
液中で接触させて、NAD’°に含有されるNAD +
活性阻害物質を除去することを特徴とするNAD+活性
阻害物質除去方法。(1) NAD+ and N containing NAD+ activity inhibitors
By contacting one or more AD'-dependent enzymes in a buffer solution, the NAD + contained in NAD'° is removed.
A method for removing an NAD+ activity inhibitor, which comprises removing an activity inhibitor.
こと全特徴とする特許請求の範囲第1項記載のNAD+
活性阻害物質除去方法。(2) NAD+ according to claim 1, which is characterized in that an NAD+-dependent enzyme is immobilized.
Method for removing activity inhibitors.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4143684A JPS60186297A (en) | 1984-03-06 | 1984-03-06 | Removal of nad+ activation inhibitor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4143684A JPS60186297A (en) | 1984-03-06 | 1984-03-06 | Removal of nad+ activation inhibitor |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS60186297A true JPS60186297A (en) | 1985-09-21 |
JPH0452117B2 JPH0452117B2 (en) | 1992-08-20 |
Family
ID=12608318
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4143684A Granted JPS60186297A (en) | 1984-03-06 | 1984-03-06 | Removal of nad+ activation inhibitor |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS60186297A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5554894A (en) * | 1978-10-13 | 1980-04-22 | Toyobo Co Ltd | Novel formaldehyde-dehydrogenase and its preparation |
JPS5816873A (en) * | 1981-07-23 | 1983-01-31 | Usac Electronics Ind Co Ltd | Regulation of stopping position of printing medium |
-
1984
- 1984-03-06 JP JP4143684A patent/JPS60186297A/en active Granted
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5554894A (en) * | 1978-10-13 | 1980-04-22 | Toyobo Co Ltd | Novel formaldehyde-dehydrogenase and its preparation |
JPS5816873A (en) * | 1981-07-23 | 1983-01-31 | Usac Electronics Ind Co Ltd | Regulation of stopping position of printing medium |
Also Published As
Publication number | Publication date |
---|---|
JPH0452117B2 (en) | 1992-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3912588A (en) | Creatine amidohydrolase in the conversion of creatinine to creatine | |
CA1128443A (en) | Process for the preparation of l-tryptophan by enzyme | |
US4064010A (en) | Purification of uricase | |
US4062731A (en) | Production of uricase from micrococcus luteus | |
US4753882A (en) | Urease and process for preparation thereof | |
JPS60186297A (en) | Removal of nad+ activation inhibitor | |
JPS6030679A (en) | Preparation of s-adenosyl-l-homocysteine hydrolase | |
Shoaf III et al. | Carbonic anhydrase of microorganisms: I. An enzyme from baker's yeast which catalyzes the formation of carbamate from ammonium bicarbonate solutions | |
JP2926249B2 (en) | Method for producing alginate lyase | |
JPS6120268B2 (en) | ||
JP2924679B2 (en) | Production method of D-lysine | |
JPH06303995A (en) | Method for determining 1,5-anhydroglucitol | |
JPH0998779A (en) | Trehalose synthetase, its production and production of trehalose using the enzyme | |
SU785318A1 (en) | Method of preparing bacterial lucipherase preparate | |
JPH0466875B2 (en) | ||
JPS62122591A (en) | Racemization of optically active 5-substituted hydantoin | |
JPS6031473B2 (en) | Method for producing polyamine oxidases using microorganisms | |
JPS6332492A (en) | Production of levorotatory optically active isomer of mandelic acid by enzymatic process | |
JPH066075B2 (en) | Method for quantifying L-amino acid and α-keto acid | |
JPH04117281A (en) | Production of betaine aldehyde dehydrogenase | |
JPS61128895A (en) | Production of useful substance using coenzyme recovery reaction | |
JPS6013665B2 (en) | Microbial polyamine oxidase AT-1 | |
JPH0240B2 (en) | ||
JPH05176794A (en) | Production of optically active 2-phenylpropionic acid and 2-phenylpropionamide | |
JPH047678B2 (en) |